Bank of New York Mellon Corp Increases Stake in Dolby Laboratories to 7.4%

2026-04-28SEC Filing SCHEDULE 13G/A (0001390777-26-000045)

The Bank of New York Mellon Corporation (BNY Mellon) has filed a Schedule 13G/A (Amendment No. 2) regarding its holdings in Dolby Laboratories, Inc. (DLB). As of the event date on March 31, 2026, the filer reported beneficial ownership of 4,499,820 shares of Class A Common Stock, representing 7.4% of the class. This indicates an increase in holdings compared to the previously reported position of 0.0%. The filing identifies several subsidiaries involved in the ownership, including BNY Mellon IHC, LLC, MBC Investments Corp, and Newton Investment Management North America, LLC, the latter of which holds a 5.4% stake. BNY Mellon holds sole voting power over 4,457,714 shares and sole dispositive power over 2,643,119 shares. The securities were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. The filing was signed on April 28, 2026, by Andrew Weiser, Attorney-In-Fact.